Comprehensive Geriatric Assessment Professors and Supervisors | ApplySharif

Find Academic Supervisors

Find and connect with academic supervisors, professors, and scholars for your research journey.

Showing 1-15 of 427 supervisors

Profile data may be stale. It is sourced from public faculty pages.

Allison Ross EckardView profile

Professor

University of Southern CaliforniaUnited States

Allison Ross Eckard, MD is Professor in the Departments of Pediatrics and Medicine at the Medical University of South Carolina (MUSC) College of Medicine, serving as Division Chief for Pediatric Infectious Diseases and Director of MUSC's Ryan White Pediatric HIV Clinic and HIV Transition Clinic. She maintains an adjunct faculty position at Emory University and holds board certification in Pediatrics and Pediatric Infectious Diseases. Her primary research focuses on metabolic, cardiovascular, and nutritional complications of chronic HIV and antiretroviral therapy across age groups, with emphasis on inflammation's role in comorbidities like cardiovascular disease and bone disorders. Current investigations include NIH R01-funded research on interventions for weight gain and abdominal fat in HIV, vitamin D supplementation, and statin therapy. She has published nearly 60 peer-reviewed papers on HIV pathogenesis and treatment optimization. Dr. Eckard co-chairs the DHHS panel for Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children and serves on the DHHS panel for Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV . Her clinical work specializes in comprehensive HIV care for children through young adults, with particular focus on adolescent/young adult transition issues and global health initiatives through Lespwa Timoun in Haiti. Recent efforts include developing COVID-19 treatment guidelines for children and school safety protocols. HIV Specialist certification (American Academy of HIV Medicine) Fellow, Infectious Diseases Society of America Fellow, Pediatric Infectious Diseases Society Fellow, HIV Medical Association Member, HIV Medical Association's 'Ending the HIV Epidemic' working group She leads MUSC's HIV education initiatives and serves as inpatient consultant for pediatric infectious diseases, with advanced training in tropical medicine. Her NIH-funded research examines targeted interventions to minimize comorbidity development in HIV, while her clinical leadership spans the Ryan White HIV program, transition clinics, and global health partnerships.

Official University Profile

Benjamin Andrew TollView profile

Professor

University of Southern CaliforniaUnited States

Benjamin Andrew Toll is a Professor in the Department of Public Health Sciences and Psychiatry at the Medical University of South Carolina (MUSC) College of Medicine. He serves as Associate Director of Education and Training for the Hollings Cancer Center, Vice Chair of Research in the Department of Public Health Sciences, Co-Director of the Lung Cancer Screening Program, and Director of the Tobacco Treatment Program at MUSC. Dr. Toll received his BA from Cornell University (1996), MS and PhD from Nova Southeastern University (1999, 2002), and completed his Postdoctoral Fellowship and Internship at Yale University. Dr. Toll is a leading researcher in tobacco cessation, with over 20 years of experience conducting clinical trials focused on developing novel therapeutics for tobacco and nicotine use. His work primarily centers on preventing cancer through tobacco treatment interventions, with particular emphasis on lung cancer screening patients and cancer surgery patients. He has expertise in nicotine replacement therapy, contingency management approaches, gain-framed messaging, and digital health interventions for smoking cessation across diverse populations including older adults and young adults. His recent publications demonstrate a strong focus on implementation science for tobacco treatment programs across various healthcare settings including hospitals, oncology clinics, and primary care. His research examines barriers to treatment, optimal delivery methods (including telehealth and EHR-integrated tools), and effectiveness of various pharmacological and behavioral interventions for smoking cessation. National Cancer Institute funding (R01CA235697, R01CA207229, P50CA196530) National Institute on Drug Abuse funding (P50DA036151, K12DA000167) Continuous funding for over 15 years for tobacco cessation research As a mentor and leader, Dr. Toll oversees the Education and Training program at the Hollings Cancer Center, guiding the development of future cancer researchers. His Tobacco Treatment Program serves as a model for integrating tobacco cessation into comprehensive cancer care, and he has successfully implemented 'opt-out' tobacco treatment programs across multiple hospital systems in South Carolina. Dr. Toll leads a multidisciplinary research team focused on tobacco treatment, including psychologists, pharmacists, physicians, and implementation scientists working together to develop and test innovative approaches to smoking cessation for high-risk populations.

Official University Profile

Dominika IgnasiakView profile

Researcher

ETH ZurichSwitzerland

Dr. Dominika Ignasiak is a Researcher affiliated with the Institute of Biomechanics at ETH Zürich. Her work focuses on spinal biomechanics, musculoskeletal modeling, and computational analysis of spinal pathologies. She contributes to understanding the biomechanical implications of surgical interventions, spinal deformities, and age-related changes in spinal alignment and loading. Her research integrates clinical data with advanced musculoskeletal modeling techniques, particularly in predicting postoperative outcomes and assessing spinal load distributions under dynamic conditions. Key areas include spinal stenosis, idiopathic scoliosis, and the biomechanics of spinal fusion surgery. Dr. Ignasiak collaborates on translational studies bridging computational simulations with clinical applications. Her publications emphasize the role of personalized models in optimizing surgical strategies and understanding degenerative spinal conditions. While no formal awards are listed, her contributions to spinal biomechanics research are evident through her active publication record in high-impact journals. Dr. Ignasiak is based at ETH Zürich’s Institute of Biomechanics, where she engages in cutting-edge research and contributes to both academic and clinical advancements in orthopedic biomechanics.

Official University Profile

Alex John LondonView profile

Professor

University of PittsburghUnited States

Alex John London is the K&L Gates Professor of Ethics and Computational Technologies at Carnegie Mellon University, where he also serves as co-lead of the K&L Gates Initiative in Ethics and Computational Technologies, Director of the Center for Ethics and Policy, and Chief Ethicist at the Block Center for Technology and Society. His work spans multiple institutions, including affiliations with the Center for Bioethics and Health Law at the University of Pittsburgh. Dr. London earned his Ph.D. in Philosophy from the University of Virginia, followed by a post-doctoral fellowship at the University of Minnesota's Center for Bioethics. He joined Carnegie Mellon University in 2000 and has established himself as a leading scholar in ethics at the intersection of technology, medicine, and policy. His academic journey includes being a Visiting Scholar at Harvard University's Program in Ethics and Health. Professor London's research spans ethical and policy issues surrounding novel technologies in medicine, biotechnology and artificial intelligence, methodological issues in theoretical and practical ethics, and cross-national issues of justice and fairness. His work in AI ethics critically examines structural obstacles to safe and effective technologies, challenges conventional notions of algorithmic bias, and questions requirements for explainability in medical contexts. His foundational work on clinical equipoise and the 'integrative approach' to risk assessment has shaped research ethics guidelines globally. He has made significant contributions to international research ethics, particularly regarding justice, responsiveness to host community health needs, and post-trial access. Professor London's scholarly output demonstrates a trajectory toward addressing the ethical challenges of emerging technologies, with increasing focus on justice-led approaches to AI innovation, accountability frameworks, and the sociotechnical dimensions of healthcare AI systems. His work increasingly addresses how AI can be designed to respect human dignity while navigating complex ethical terrain in healthcare settings. New Directions Fellowship from the Andrew W. Mellon Foundation (2005, 2010) Hastings Center Fellow (2011) Elliott Dunlap Smith Award for Distinguished Teaching (2016) Distinguished Service Award from the American Society of Bioethics and Humanities (2017) As an educator, Professor London teaches courses on ethical theory, bioethics, ethics and AI, and research ethics. His influential textbook 'Ethical Issues in Modern Medicine' (8th edition) is one of the most widely used resources in medical ethics education. His book 'For the Common Good: Philosophical Foundations of Research Ethics' (2022) provides a comprehensive framework for understanding research ethics as serving the common good. Professor London has advised numerous students and mentored early-career researchers in bioethics and technology ethics. His policy work extends to multiple national and international organizations including the World Health Organization Expert Group on Ethics and Governance of AI, the National Academy of Medicine Action Collaborative, and the U.S. National Science Advisory Board for Biosecurity. Professor London leads several significant research initiatives, including serving as co-leader of the ethics core for the NSF AI Institute for Collaborative Assistance and Responsive Interaction for Networked Groups (AI-CARING). His Center for Ethics and Policy at CMU serves as a hub for interdisciplinary research addressing pressing ethical challenges in technology and healthcare. He is actively involved in shaping policy through his membership on the steering committee of the AAAI/ACM Conference on Artificial Intelligence, Ethics and Society (AIES) and his co-chair role in the U.S. National Academies planning committee on computational modeling of biological agents.

Official University Profile

Laura J. BalcerView profile

Professor

New York UniversityUnited States

Dr. Laura J. Balcer is a Professor in the Departments of Neurology, Ophthalmology, and Population Health at NYU Grossman School of Medicine. She specializes in Neuro-Ophthalmology and serves as the Director of DAPC/Faculty Affairs and Vice Chair of the Department of Neurology. Since joining NYU Langone in 2012, she has been dedicated to mentoring trainees and advancing research in neurological disorders, particularly focusing on vision-related issues linked to brain conditions like multiple sclerosis and concussions. Dr. Balcer's educational background includes: MD from Johns Hopkins University (1991) Residency in Neurology at the Hospital of the University of Pennsylvania (1995) Fellowship in Neuro-Ophthalmology at the Hospital of the University of Pennsylvania (1996) Her research interests center on neuro-ophthalmology, concussion assessment, and multiple sclerosis. She is renowned for pioneering the use of vision testing, such as the King-Devick test, to diagnose concussions in athletes and improve patient care through interdisciplinary collaboration. Her work bridges clinical practice and technology, including mobile health applications for cognitive assessment. Her recent research explores innovative diagnostic tools, such as tablet-based assessments for Alzheimer’s and mobile applications for concussion evaluation, reflecting her commitment to advancing early detection and treatment strategies in neurology. In addition to her clinical and research contributions, Dr. Balcer has mentored numerous trainees and secured grants to study neurological disorders. Her work is supported by initiatives such as the DIAGNOSE CTE Research Project and studies on vision-related biomarkers. She collaborates with the NYU Langone Concussion Center and interdisciplinary teams including rehabilitation doctors, sports medicine experts, and therapists to provide comprehensive patient care.

Official University Profile

Brandon K. KoretzView profile

Clinical Professor

University of California, Los AngelesUnited States

Brandon K. Koretz, MD, MBA, is a Clinical Professor at the David Geffen School of Medicine at UCLA and holds the Carol and Jim Collins Endowed Chair. He specializes in Geriatric Medicine and serves as a primary care provider, focusing on comprehensive Geriatric Assessment and consultations. His administrative roles include President of the Department of Medicine Professional Group (four terms) and Interim CEO/President of the UCLA Faculty Practice Group. Currently, he sits on the UCLA Faculty Senate Executive Board. Education: BA in Psychology (UC Berkeley, 1992), MD (UCSF, 1996), MBA (UCLA Anderson School of Management, 2013). Certifications: Geriatric Medicine (American Board of Internal Medicine, 2000). Research Interests: Quality Improvement in healthcare systems and patient care processes. Dr. Koretz is renowned for his teaching excellence, earning multiple awards including the Eby Award for Teaching and the Teaching Humanism at the Bedside Award. He emphasizes communication, leadership, and customer service in medical education. His clinical practice focuses on aging-related conditions like memory disorders, polypharmacy, and dementia. He is affiliated with Ronald Reagan UCLA Medical Center and UCLA Santa Monica Medical Center. Awards & Recognition: Super Doctors® Southern California (2022–2025), Top Doctors (Los Angeles Magazine, 2021), Phi Beta Kappa (1992).

Official University Profile

Steven K. RothschildView profile

Professor

Rush UniversityUnited States

Dr. Steven K. Rothschild is Professor and Chair of the Department of Family & Preventive Medicine at Rush Medical College, Rush University, where he also holds the distinguished title of The Roger C. Bone, MD, Presidential Professor. As a practicing family physician at Rush Family Physicians in Chicago (1700 W Van Buren St, Suite 470), he provides comprehensive primary care with particular expertise in managing patients with multiple chronic conditions, especially older adults. His educational background includes: Medical Degree from University of Michigan Medical School Residency in Family Medicine at Cleveland Metropolitan General Hospital Dr. Rothschild describes his clinical approach as being 'the conductor of the orchestra' for complex patients, ensuring medication regimens don't conflict and diagnostic testing is coordinated efficiently. With patients he's seen for 20-25 years, he emphasizes the importance of long-term patient-physician relationships and continuity of care. His patient satisfaction ratings consistently average 4.9/5.0 across multiple dimensions including communication, empathy, and shared decision-making. Analysis of his 22 publications from 2003-2024 reveals three dominant research themes: community health worker interventions (particularly for diabetes management in Hispanic populations), integrated care models addressing both medical and social determinants of health, and mental health interventions within primary care settings. His recent work increasingly incorporates digital health technologies for depression, anxiety, and sleep interventions. As Department Chair, Dr. Rothschild oversees academic programs, faculty development, and research initiatives within Family & Preventive Medicine. His leadership focuses on training the next generation of family physicians while advancing innovative approaches to primary care delivery for complex patient populations.

Official University Profile

Lisa DuizerView profile

Professor

University of GuelphCanada

Lisa Duizer serves as Professor and Department Chair in the Department of Food Science at the University of Guelph, where she has been faculty since 2009 after previous appointments at Acadia University's School of Nutrition and Dietetics and Massey University's Institute of Food Nutrition and Human Health. Her research addresses critical challenges in food for aging populations, focusing on sensory properties of foods designed for older adults with dysphagia or malnutrition. Education BASc in Applied Human Nutrition, University of Guelph (1990) MSc in Food Science, University of Guelph (1992) PhD in Food Technology, Massey University (2003) Research Interests Professor Duizer's work centers on sensory science applications for geriatric nutrition, investigating age-related changes in taste and texture perception. She develops evidence-based strategies for improving nutritional quality and acceptability of foods for elderly populations, including pureed food optimization, nutrient fortification techniques, and 'supermenu' development for long-term care settings. Her research integrates human subjects testing with rheological and tribological analysis to establish science-based standards for modified texture foods. Publication Trends Her recent publications (2022-2025) demonstrate expanding interdisciplinary scope, with increasing focus on emotional food responses, space food sensory perception, and plant-based alternatives. The predominant themes involve texture modification for dysphagia management, salt reduction strategies for older adults, and stakeholder-driven interventions for malnutrition in long-term care. This trajectory reflects growing integration of sensory science with healthcare delivery systems and innovative food product development. Scientific Awards No scientific awards were documented in the provided source materials. Advising and Grants Lisa Duizer mentors graduate students with rigorous emphasis on ethical conduct in human subjects research, requiring comprehensive understanding of participant interaction protocols. Her students from nutrition and food science backgrounds have pursued careers as registered dietitians, food product developers in multinational corporations, and research scientists. Her work with the Agri-Food for Healthy Aging group and University Health Network affiliation indicates substantial grant funding from health and agriculture sectors for projects targeting malnutrition intervention in aging populations. Labs and Teams She leads sensory evaluation laboratories within the Department of Food Science and serves as Research Scientist for the Agri-Food for Healthy Aging initiative. Her collaborative network includes the University Health Network, Ontario Ministry of Health and Long-Term Care, long-term care home operators, food distributors, and agricultural producers, facilitating translational research from laboratory to institutional meal service implementation.

Official University Profile

Echu LiuView profile

Professor

Saint Louis UniversityUnited States

Echu Liu is a Professor in the Department of Health Management and Policy at the College for Public Health and Social Justice, Saint Louis University. He also serves as the Director of the Ph.D. in Public Health Studies program, contributing significantly to academic leadership and public health education. Education: Ph.D. in Economics, University of Southern California, 2006 M.B.A. in Finance, California State University, Los Angeles, 2000 M.A. in Economics, National Taiwan University/University of Southern California, 1995/2003 B.A. in Economics, National Taiwan University, 1994 Dr. Liu's research focuses on health policy, health economics, data analytics, and health insurance literacy . His work examines how socioeconomic factors, health literacy, and insurance understanding influence healthcare access, financial burden, and health outcomes across diverse populations, including international students, older adults, and racial minorities. His interdisciplinary approach integrates economics, public health, and biostatistics to inform policy and improve health equity. His recent publications (2009–2025) reflect a consistent trajectory in health economics and policy analysis , with a strong emphasis on health insurance literacy, medical debt, pandemic behavior, and global health disparities . The studies employ rigorous econometric and statistical methods, often using large national surveys from the U.S., China, and India. Key themes include the impact of policy interventions, socioeconomic determinants of health, and behavioral responses to healthcare systems. Professional Service: Associate Editor, Health Economics Section, Frontiers in Public Health Dr. Liu teaches Biostatistics, Health Care Economics, and Healthcare Financial Management , equipping students with analytical and financial tools for public health leadership. While specific advisees are not listed, his role as Ph.D. program director and frequent collaboration with researchers suggests active mentorship. His research has been supported by institutional and likely external funding, though specific grants are not detailed. He maintains an active scholarly presence through high-impact journal publications and editorial contributions. Laboratory and Research Teams: While no formal lab is mentioned, Dr. Liu leads and collaborates with interdisciplinary research teams focused on health policy analysis, data-driven public health, and socioeconomic determinants of health. His work often involves partnerships with public health scholars, economists, and data scientists.

Official University Profile

Cynthia H.Y. FuView profile

Professor

University of East LondonUnited Kingdom

Professor Cynthia H.Y. Fu is a leading researcher in the Department of Psychology & Human Development at the University of East London's School of Childhood and Social Care. She serves as an Honorary Consultant Psychiatrist at the South London and Maudsley NHS Foundation Trust and holds a Visiting Professor position at the Centre for Affective Disorders, King's College London. Her research focuses on identifying brain regions affected by depression and how they change with various treatments including talking therapies, antidepressant medication, and neurostimulation techniques like transcranial direct current stimulation (tDCS). Professor Fu pioneered work demonstrating that neural activation patterns during sad facial processing can accurately diagnose depression in individual patients and predict treatment response. Her research has direct translational potential in developing biomarkers for diagnosis and prognosis based on brain imaging. Professor Fu's work spans multiple disciplines including affective neuroscience, computational psychiatry, and neuromodulation. Her recent publications reveal strong trends in applying machine learning to neuroimaging data for depression classification, investigating home-based tDCS treatment protocols, and exploring the relationship between physiological markers and psychological states in real-world contexts like driving and commuting. British Association for Psychopharmacology Award National Alliance for Research in Schizophrenia and Depression (Brain & Behavior Research Foundation) Award Professor Fu has secured significant research funding from major organizations including the Medical Research Council, Wellcome Trust, GlaxoSmithKline, and Eli Lilly. Her work regularly appears in top-tier journals and is consistently cited among the most influential publications in psychiatry. She leads research investigating how brain responses can predict individual treatment responses, potentially enabling personalized depression treatment approaches. Her laboratory focuses on multimodal neuroimaging approaches combined with machine learning to identify neural signatures of depression and treatment response. Current projects include home-based tDCS treatment protocols with remote supervision, biomarker development for predicting antidepressant response, and computational approaches to understanding stress responses in everyday contexts.

Official University Profile

Richard O'DonnellView profile

Clinical Professor

University of California, San FranciscoUnited States

Richard O'Donnell is a Clinical Professor of Orthopaedic Surgery at the University of California San Francisco, where he holds leadership roles as Founder of the Orthopaedic Surgical Osseointegration Society (OSOS) and Director of both the UCSF Musculoskeletal Research Consortium (METRiCS) and the UCSF international Center for Osseointegration Research, Education, and Surgery (iCORES). Previously, he served as Chief of the Orthopaedic Oncology Service (2002-2019) and Director of the Sarcoma Program at the UCSF Helen Diller Family Comprehensive Cancer Center (through 2023). His educational background includes an A.B. in Biology from Harvard College (1985), an M.D. from Harvard Medical School (1989), Orthopaedic Surgery Residency through the Harvard Combined Orthopaedic Program (1995), and a Musculoskeletal Oncology Fellowship at the University of Washington (1996). Additional appointments include Extramural Member of the Department of Defense Osseointegration Program Steering Committee and Visiting Professor of Surgery at Harvard Medical School, with service under the American Red Cross at Walter Reed National Military Medical Center. O'Donnell's research focuses on orthopaedic oncology, sarcoma management, and osseointegration technologies, with significant contributions to musculoskeletal tumor surgery and limb preservation. His work bridges clinical innovation and translational research, particularly in endoprosthetic reconstruction and infection prevention. During the pandemic, he spearheaded international studies on cancer surgery safety, demonstrating adaptability in crisis response while maintaining oncologic priorities. His publication trends reveal dual expertise: pre-pandemic work centered on bone tumors and sarcoma outcomes, while recent research addresses pandemic-era surgical challenges through large global collaborations like COVIDSurg and PARITY. This pivot highlights his leadership in maintaining cancer care continuity during health crises while advancing foundational orthopaedic oncology. Best Paper Award, Musculoskeletal Tumor Society Annual Meeting (2018) Top Doctors recognition by Marin Magazine and San Francisco Magazine (2017-2020) Bishop's Distinguished Catholic Alumni Award, Diocese of Allentown (2017) As principal investigator for multi-institutional trials including PARITY (antibiotic regimens in tumor surgery) and FORCE (endoprosthetic outcomes), O'Donnell secures significant collaborative funding. His mentorship extends through OSOS and iCORES, fostering international networks for osseointegration research. Current grants support pandemic-responsive surgical frameworks and sarcoma treatment optimization. He leads the UCSF Musculoskeletal Research Consortium (METRiCS) and iCORES, which coordinate translational research across orthopaedic oncology, osseointegration, and surgical innovation. These centers facilitate industry partnerships for prosthetic development and maintain active clinical trial portfolios, with iCORES specifically advancing global education in osseointegration techniques.

Official University Profile

Nicole DezielView profile

Associate Professor

Yale UniversityUnited States

Nicole Deziel is an Associate Professor of Epidemiology in the Department of Environmental Health Sciences at the Yale School of Public Health. She also holds secondary appointments as Associate Professor in Chemical and Environmental Engineering and the School of the Environment. Dr. Deziel serves as Co-Director of the Yale Center for Perinatal, Pediatric and Environmental Epidemiology (CPPEE) and leads the Deziel Exposure Science Lab. Dr. Deziel earned her PhD and Master's of Health Science (MHS) in Environmental Health from the Johns Hopkins Bloomberg School of Public Health in 2008 and 2000, respectively. Her academic journey has positioned her as a leading researcher in environmental exposure science and epidemiology. Dr. Deziel's research focuses on applying statistical models, biomonitoring techniques, and environmental measurements to provide comprehensive assessments of exposure to traditional and emerging environmental contaminants in population-based studies. Her work primarily investigates two critical areas: (1) exposure and human health impacts of unconventional oil and gas development ("hydraulic fracturing") and (2) residential exposure to chemicals in common consumer products (e.g., pesticides, flame retardants) and cancer risk, particularly thyroid cancer. She integrates environmental justice considerations into her research, examining disproportionate burdens of exposures and the combination of environmental and social stressors. Her research uses a combination of large administrative datasets and detailed community-focused studies to advance understanding of environmental exposures to chemicals, particularly carcinogens and endocrine disruptors. Her recent publications demonstrate a strong focus on perinatal and pediatric environmental health, with significant work on air pollution impacts on childhood cancer, PFAS exposures and child development, and environmental justice issues related to superfund sites and oil and gas development. The research shows consistent methodological rigor, often employing sophisticated spatial analysis and exposure assessment techniques to address complex environmental health questions. Dr. Deziel has received notable recognition for her work, including: Yale Cancer Center Population Science Research Prize (2020) Joan M. Daisey Outstanding Young Exposure Scientist Award from the International Society of Exposure Science (2018) As Co-Director of the Center for Perinatal, Pediatric and Environmental Epidemiology, Dr. Deziel leads interdisciplinary research efforts examining how environmental exposures affect child health outcomes. Her lab conducts fieldwork and analysis on environmental effects on drinking water, hydraulic fracturing impacts, and the relationship between flame retardants and cancer risk. She collaborates extensively with researchers across Yale, particularly with Dr. Xiaomei Ma (18 joint publications), Dr. Joshua Warren (12 joint publications), and other experts in biostatistics, environmental health, and cancer epidemiology.

Official University Profile

John Day GazewoodView profile

Associate Professor

University of VirginiaUnited States

John Day Gazewood, MD is an Associate Professor in the Department of Family Medicine at the University of Virginia . As the current Residency Program Director and Medical Director of the Primary Care Center , he focuses on enhancing medical education and improving patient care quality for the elderly and those with chronic illnesses. His academic journey includes a Chemistry degree from Grinnell College (Phi Beta Kappa) MD from Vanderbilt University School of Medicine (Alpha Omega Alpha) Residency in Family Medicine at University of Missouri-Columbia Geriatric Fellowship and Master of Science in Public Health at University of Missouri-Columbia Research interests center on medical education reform , geriatric care integration , and chronic disease management . His publications span topics like Bell's Palsy , Heart Failure , and Rosacea treatment , emphasizing evidence-based primary care. Awards include Best Doctors in America (2008, 2010, 2012) Harrison Teaching Associate Professor Master Educator Award Dean's Award for Excellence in Teaching Patient testimonials highlight exceptional care, clear communication, and responsiveness. He has served on the Geriatric Board Exam committee and maintains dual board certifications in Family Medicine and Geriatrics .

Official University Profile

James P ChandlerView profile

Professor

Northwestern UniversityUnited States

James P Chandler, MD, FACS serves as Vice Chair for Clinical Affairs and Lavin/Fates Professor of Neurological Surgery at Northwestern University's Feinberg School of Medicine. He also holds professorships in the Ken and Ruth Davee Department of Neurology and Department of Otolaryngology - Head and Neck Surgery. Dr. Chandler is the Rudy E. Sabbagha Distinguished Physician and founder/Surgical Director of the Lou and Jean Malnati Brain Tumor Institute at Northwestern University's Comprehensive Cancer Center. His educational background includes: MD from University of Maryland (1990) Residency in Neurological Surgery at Northwestern University Fellowship training in cranial base and microvascular surgery at Instituto Neurologico De São Paulo (Brazil) Additional fellowship at George Washington Neurological Institute Dr. Chandler specializes in brain and spine tumors with particular expertise in skull base tumors and minimally invasive procedures. His research focuses on endoscopic techniques and Gamma Knife radiosurgery as alternatives to conventional open cranial base surgery. He created Northwestern's Skull Base Laboratory in 2016, which provides advanced anatomical and surgical research opportunities for residents and faculty. His clinical practice encompasses treatment of gliomas, meningiomas, pituitary adenomas, craniopharyngiomas, chordomas, acoustic neuromas/schwannomas, trigeminal neuralgia, hemifacial spasm, and metastatic brain tumors, having performed over 6,000 successful brain surgeries throughout his career. His recent publications demonstrate strong focus on meningioma genetics, hydrocephalus diagnostics, and sellar region tumors, reflecting his dual expertise in surgical technique and molecular tumor biology. Award highlights include: Multiple consecutive 'Top Doctors' designations from Castle Connolly and Chicago Magazine (2022-2024) Alpha Omega Alpha Honor Medical Society membership (2019) Rudy E. Sabbagha Distinguished Physician award (2010) Humanitarian Award from Northwestern Memorial Hospital (2010) Multiple 'Best Doctors in America' recognitions (2008-2011) Dr. Chandler hosts an annual international surgical techniques course and maintains extensive professional society involvement including the American Association of Neurological Surgeons, Congress of Neurological Surgeons, and North American Skull Base Society. His Skull Base Laboratory serves as a key training facility for advanced neurosurgical techniques.

Official University Profile

David PeeblesView profile

Professor

University of HuddersfieldUnited Kingdom

David Peebles is Professor and Director of the Centre for Cognition and Neuroscience at the University of Huddersfield's School of Human and Health Sciences. His research develops computational cognitive models to understand human interaction with external information representations, using the ACT-R cognitive architecture to investigate diagrammatic reasoning and problem-solving. Peebles' work examines how people interpret complex visualizations like graphs, maps, and interfaces, with applications in healthcare training, legal decision-making, and autonomous systems. His recent research explores dementia assessment methodologies, lie detection paradigms, and immersive technologies for medical education. The work integrates experimental psychology with computational modeling to understand high-level cognitive processes.

Official University Profile